Caribou Biosciences to Present at Upcoming Investor Conferences
20 oct. 2021 16h00 HE
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng to its Board of Directors
29 sept. 2021 16h05 HE
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today it has...
Caribou Biosciences to Participate in the Chardan Virtual 5th Annual Genetic Medicines Conference
27 sept. 2021 16h05 HE
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
Caribou Biosciences Provides Business Update and Reports Second Quarter 2021 Financial Results
02 sept. 2021 16h05 HE
|
Caribou Biosciences, Inc.
Completed upsized initial public offering of common stock, raising $349.6 million in gross proceeds including full exercise of underwriters’ option to purchase additional shares ANTLER Phase 1...
Caribou Biosciences Announces Publication of Data Demonstrating High Specificity Genome Editing with its Proprietary chRDNA Technology
02 sept. 2021 16h05 HE
|
Caribou Biosciences, Inc.
Data published in Molecular Cell provide a mechanistic framework to explain the enhanced specificity and key differentiation of Caribou’s proprietary chRDNA technology for therapeutic applications ...
Caribou Biosciences to Participate in Citi’s 16Th Annual BioPharma Virtual Conference
01 sept. 2021 08h00 HE
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
Caribou Biosciences Appoints Nancy Whiting, Pharm.D., to its Board of Directors
25 août 2021 16h00 HE
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that it has...